MOH — authorised 29 April 2016
- Marketing authorisation holder: ACADIA PHARMACEUTICALS INC
- Status: likely_approved
MOH authorised Nuplazid on 29 April 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 29 April 2016.
ACADIA PHARMACEUTICALS INC holds the UAE marketing authorisation.